The future of respiratory care is shifting.
LungCare aims to move from invasive procedures to non-invasive breath diagnostics and targeted nanotherapies.
Follow us to track our progress.
#LungCare#Nanomedicine#HorizonEurope#LungHealth#MSCA
How can nanomedicine transform lung health?
LungCare develops innovative strategies—from vaccines against Pseudomonas aeruginosa to inhalable nanotherapies and advanced diagnostics for TB and lung cancer.
#LungCare#MSCA#LungHealth#Nanomedicine#HorizonEurope
LungCare brings together a global consortium of academic and industrial partners working at the interface of nanomedicine, biotechnology and respiratory health.
Together, we aim to develop innovative solutions for the diagnosis and treatment of lung diseases.
#LungCare
Lung diseases remain a major global health challenge. LungCare focuses on three critical targets: lung cancer, tuberculosis, and bacterial pneumonia -developing innovative nanomedicine tools for better diagnosis and treatment.
#LungCare#LungHealth#HorizonEurope#MSCA
Lung diseases remain a major global health challenge. LungCare brings together an international interdisciplinary consortium to develop nanomedicine solutions for lung diseases—from vaccines against Pseudomonas aeruginosa to Tuberculosis diagnostics and lung cancer sensors.